Diagnosis of Childhood Tuberculosis and Host RNA Expression in Africa
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Improved diagnostic tests for tuberculosis in children are needed. We hypothesized that transcriptional signatures of host blood could be used to distinguish tuberculosis from other diseases in African children who either were or were not infected with the human immunodeficiency virus (HIV). METHODS: The study population comprised prospective cohorts of children who were undergoing evaluation for suspected tuberculosis in South Africa (655 children), Malawi (701 children), and Kenya (1599 children). Patients were assigned to groups according to whether the diagnosis was culture-confirmed tuberculosis, culture-negative tuberculosis, diseases other than tuberculosis, or latent tuberculosis infection. Diagnostic signatures distinguishing tuberculosis from other diseases and from latent tuberculosis infection were identified from genomewide analysis of RNA expression in host blood. RESULTS: We identified a 51-transcript signature distinguishing tuberculosis from other diseases in the South African and Malawian children (the discovery cohort). In the Kenyan children (the validation cohort), a risk score based on the signature for tuberculosis and for diseases other than tuberculosis showed a sensitivity of 82.9% (95% confidence interval [CI], 68.6 to 94.3) and a specificity of 83.6% (95% CI, 74.6 to 92.7) for the diagnosis of culture-confirmed tuberculosis. Among patients with cultures negative for Mycobacterium tuberculosis who were treated for tuberculosis (those with highly probable, probable, or possible cases of tuberculosis), the estimated sensitivity was 62.5 to 82.3%, 42.1 to 80.8%, and 35.3 to 79.6%, respectively, for different estimates of actual tuberculosis in the groups. In comparison, the sensitivity of the Xpert MTB/RIF assay for molecular detection of M. tuberculosis DNA in cases of culture-confirmed tuberculosis was 54.3% (95% CI, 37.1 to 68.6), and the sensitivity in highly probable, probable, or possible cases was an estimated 25.0 to 35.7%, 5.3 to 13.3%, and 0%, respectively; the specificity of the assay was 100%. CONCLUSIONS: RNA expression signatures provided data that helped distinguish tuberculosis from other diseases in African children with and those without HIV infection. (Funded by the European Union Action for Diseases of Poverty Program and others).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Panels containing a limited number of host biomarkers are being developed as diagnostic assays for influenza77, tuberculosis70 and bacterial sepsis78.”
From Clinical metagenomics (2019) · cites this paper as [70]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regularization and Variable Selection Via the Elastic Net
Zou, H., & Hastie, T. (2005) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.1467-9868.2005.00503.x · Cited by 20,957
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
Self-citationPerez-Velez, C. M., & Marais, B. J. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1008049 · Cited by 572
Zar, H. J., Hanslo, D., Apolles, P., Swingler, G., & Hussey, G. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17702-2 · Cited by 511
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
Wallis, R. S., Pai, M., Menzies, D., Doherty, T. M., Walzl, G., Perkins, M. D., & Zumla, A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60359-5 · Cited by 453
Kaforou, M., Wright, V. J., Oni, T., French, N., Anderson, S. T., Bangani, N., Banwell, C. M., Brent, A. J., Crampin, A. C., Dockrell, H. M., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001538 · Cited by 371
Self-citationNicol, M. P., Workman, L., Isaacs, W., Munro, J., Black, F., Eley, B., Boehme, C. C., Zemanay, W., & Zar, H. J. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70167-0 · Cited by 338
Self-citationChintu, C., Mudenda, V., Lucas, S., Nunn, A., Lishimpi, K., Maswahu, D., Kasolo, F., Mwaba, P., Bhat, G., Terunuma, H., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11082-8 · Cited by 333
Graham, S. M., Ahmed, T., Amanullah, F., Browning, R., Cardenas, V., Casenghi, M., Cuevas, L. E., Gale, M., Gie, R. P., Grzemska, M., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis008 · Cited by 325
Cited by
Chiu, C. Y., & Miller, S. A. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0113-7 · Cited by 1,620
A blood RNA signature for tuberculosis disease risk: a prospective cohort study
Zak, D. E., Penn-Nicholson, A., Scriba, T. J., Thompson, E., Suliman, S., Amon, L. M., Mahomed, H., Erasmus, M., Whatney, W., Hussey, G. D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01316-1 · Cited by 780
Self-citationDheda, K., Barry, C. E., & Maartens, G. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00151-8 · Cited by 599
Drain, P. K., Bajema, K. L., Dowdy, D., Dheda, K., Naidoo, K., Schumacher, S. G., Ma, S., Meermeier, E., Lewinsohn, D. M., & Sherman, D. R. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00021-18 · Cited by 565
Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis
Sweeney, T. E., Braviak, L., Tato, C. M., & Khatri, P. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)00048-5 · Cited by 445
T cells and adaptive immunity to Mycobacterium tuberculosis in humans
Jasenosky, L. D., Scriba, T. J., Hanekom, W. A., & Goldfeld, A. E. (2015) · Immunological Reviews · doi:10.1111/imr.12274 · Cited by 362
“An inflammatory signature appears to also occur in children with TB, and a transcriptomic signature consisting largely of type I/II interferon genes has recently been applied as a diagnostic test for TB in children (154).”
MethodTuberculosis: advances and challenges in development of new diagnostics and biomarkers
Walzl, G., McNerney, R., du Plessis, N., Bates, M., McHugh, T. D., Chegou, N. N., & Zumla, A. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30111-7 · Cited by 341
“evaluated mRNA transcript signatures in children with suspected tuberculosis from South Africa, Kenya and Malawi and compared with the profiles of children with LTBI and other diseases.(35) A 51-transcript biosignature, diagnosed culture-confirmed tuberculosis disease in the validation sample set with a sensitivity of…”
ResultHerberg, J. A., Kaforou, M., Wright, V. J., Shailes, H., Eleftherohorinou, H., Hoggart, C. J., Cebey-López, M., Carter, M. J., Janes, V. A., Gormley, S., et al. (2016) · JAMA · doi:10.1001/jama.2016.11236 · Cited by 324
Self-citationType I interferons in tuberculosis: Foe and occasionally friend
Moreira-Teixeira, L., Mayer-Barber, K., Sher, A., & O’Garra, A. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180325 · Cited by 282
“…et al., 2013 South Africa, Malawi Whole blood Active TB (HIV−/+; n = 195); LTBI (HIV−/+; n = 167) o o Cai et al., 2014 China PBMCs active TB (n = 9); LTBI (n = 6); HC (n = 6) o Anderson et al., 2014 Kenya Whole blood Active TB (n = 79); LTBI (n = 14) o South Africa, Malawi Active TB (n =…”
BackgroundHost gene expression classifiers diagnose acute respiratory illness etiology
Tsalik, E. L., Henao, R., Nichols, M., Burke, T., Ko, E. R., McClain, M. T., Hudson, L. L., Mazur, A., Freeman, D. H., Veldman, T., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad6873 · Cited by 254
A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes
Roy Chowdhury, R., Vallania, F., Yang, Q., Lopez Angel, C. J., Darboe, F., Penn-Nicholson, A., Rozot, V., Nemes, E., Malherbe, S. T., Ronacher, K., et al. (2018) · Nature · doi:10.1038/s41586-018-0439-x · Cited by 243
A systematic review of biomarkers to detect active tuberculosis
MacLean, E., Broger, T., Yerlikaya, S., Fernandez-Carballo, B. L., Pai, M., & Denkinger, C. M. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0380-2 · Cited by 220
Mahajan, P., Kuppermann, N., Mejias, A., Suarez, N., Chaussabel, D., Casper, T. C., Smith, B., Alpern, E. R., Anders, J., Atabaki, S. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.9207 · Cited by 212
Gupta, R. K., Turner, C. T., Venturini, C., Esmail, H., Rangaka, M. X., Copas, A., Lipman, M., Abubakar, I., & Noursadeghi, M. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30282-6 · Cited by 196
Tuberculosis Diagnostics in 2015: Landscape, Priorities, Needs, and Prospects
Pai, M., & Schito, M. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu803 · Cited by 193
“These biomarkers include a combination of biological measurements at the protein or genomic level that reflect an interaction between the host and the pathogen [31, 32].”
BackgroundThe transmission of Mycobacterium tuberculosis in high burden settings
Yates, T. A., Khan, P. Y., Knight, G. M., Taylor, J. G., McHugh, T. D., Lipman, M., White, R. G., Cohen, T., Cobelens, F. G., Wood, R., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00499-5 · Cited by 192
Host blood RNA signatures predict the outcome of tuberculosis treatment
Thompson, E. G., Du, Y., Malherbe, S. T., Shankar, S., Braun, J., Valvo, J., Ronacher, K., Tromp, G., Tabb, D. L., Alland, D., et al. (2017) · Tuberculosis · doi:10.1016/j.tube.2017.08.004 · Cited by 181
“[5].”
The potential of using blood circular RNA as liquid biopsy biomarker for human diseases
Wen, G., Zhou, T., & Gu, W. (2021) · Protein & Cell · doi:10.1007/s13238-020-00799-3 · Cited by 177
Tuberculosis Biomarkers: From Diagnosis to Protection
Goletti, D., Petruccioli, E., Joosten, S. A., & Ottenhoff, T. H. M. (2016) · Infectious Disease Reports · doi:10.4081/idr.2016.6568 · Cited by 173
Self-citationGoletti, D., Lee, M., Wang, J., Walter, N., & Ottenhoff, T. H. M. (2018) · Respirology · doi:10.1111/resp.13272 · Cited by 165
Self-citationWarsinske, H., Vashisht, R., & Khatri, P. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002786 · Cited by 162
Kanabalan, R. D., Lee, L. J., Lee, T. Y., Chong, P. P., Hassan, L., Ismail, R., & Chin, V. K. (2021) · Microbiological Research · doi:10.1016/j.micres.2020.126674 · Cited by 158
The human immune response to tuberculosis and its treatment: a view from the blood
Cliff, J. M., Kaufmann, S. H. E., McShane, H., van Helden, P., & O'Garra, A. (2015) · Immunological Reviews · doi:10.1111/imr.12269 · Cited by 159
Loxton, A. G., Knaul, J. K., Grode, L., Gutschmidt, A., Meller, C., Eisele, B., Johnstone, H., van der Spuy, G. D., Maertzdorf, J., Kaufmann, S. H. E., et al. (2017) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00439-16 · Cited by 176
Pathophysiological Mechanisms of Asthma
Bush, A. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00068 · Cited by 196
“Omics Technology It is well known that asthma is poorly diagnosed (162– 164), often objective diagnostic tests are not used, and those that are available are so crude when compared with the gene signature approaches used, for example, in tuberculosis diagnostics (165, 166).”
BackgroundOliwa, J. N., Karumbi, J., Marais, B. J., Madhi, S. A., & Graham, S. M. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00028-4 · Cited by 175
Bacterial Factors That Predict Relapse after Tuberculosis Therapy
Colangeli, R., Jedrey, H., Kim, S., Connell, R., Ma, S., Venkata, U. D. C., Chakravorty, S., Gupta, A., Sizemore, E. E., Diem, L. A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1715849 · Cited by 145
Suliman, S., Geldenhuys, H. D., Johnson, J. L., Hughes, J., Smit, E., Murphy, M., Toefy, A., Lerumo, L., Hopley, C., Pienaar, B., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501996 · Cited by 156
Thomas, T. A. (2017) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2017.03.010 · Cited by 197
Warsinske, H., Rao, A., Moreira, F. M. F., dos Santos, P. C. P., Liu, A. B., Scott, M. K. D., Malherbe, S. T., Ronacher, K., Walzl, G., Winter, J. A., et al. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.3779 · Cited by 133
Tuberculosis Diagnostics: State of the Art and Future Directions
Pai, M., Nicol, M. P., & Boehme, C. C. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0019-2016 · Cited by 149
Point of care diagnostics for tuberculosis
García‐Basteiro, A. L., DiNardo, A. R., Saavedra, B., Silva, D. R., Palmero, D., Gegia, M., Migliori, G. B., Duarte, R., Mambuque, E., Centis, R., et al. (2018) · Pulmonology · doi:10.1016/j.rppnen.2017.12.002 · Cited by 149
“Other relevant study showed that host mRNA signature from host blood can differentiate tuberculosis from other diseases in several cohorts of African children, regardless of HIV infection.(155) However, the equipment and complexity involved in the analysis of transcriptional signatures preclude their use in POC for no…”
BackgroundKay, A. W., Fernández, L. G., Takwoingi, Y., Eisenhut, M., Detjen, A., Steingart, K. R., & Mandalakas, A. M. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013359.pub2 · Cited by 153
Diagnosis of Kawasaki Disease Using a Minimal Whole-Blood Gene Expression Signature
Wright, V., Herberg, J. A., Kaforou, M., Shimizu, C., Eleftherohorinou, H., Shailes, H., Barendregt, A. M., Menikou, S., Gormley, S., Berk, M., et al. (2018) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2018.2293 · Cited by 133
“Disease Risk Score and Assessment ofModel Accuracy We applied the previously reported disease risk score (DRS) method that assigns individual disease risk based on the transcripts in the diagnostic signature.(15) The DRS combines the fluorescence intensity of upregulated transcripts and subtracts the combined fluoresc…”
Self-citationTurner, C. T., Gupta, R. K., Tsaliki, E., Roe, J. K., Mondal, P., Nyawo, G. R., Palmer, Z., Miller, R. F., Reeve, B. W. P., Theron, G., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30469-2 · Cited by 145
Singhania, A., Wilkinson, R., Rodrigue, M., Haldar, P., & O’Garra, A. (2018) · Nature Immunology · doi:10.1038/s41590-018-0225-9 · Cited by 136
Self-citationAssessment of immune status using blood transcriptomics and potential implications for global health
Chaussabel, D. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.002 · Cited by 111
The C-Type Lectin Receptor CLECSF8/CLEC4D Is a Key Component of Anti-Mycobacterial Immunity
Wilson, G. J., Marakalala, M. J., Hoving, J. C., van Laarhoven, A., Drummond, R. A., Kerscher, B., Keeton, R., van de Vosse, E., Ottenhoff, T. H. M., Plantinga, T. S., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.01.004 · Cited by 124
“(Anderson et al., 2014).”
Self-citationTuberculosis-Associated MicroRNAs: From Pathogenesis to Disease Biomarkers
Sinigaglia, A., Peta, E., Riccetti, S., Venkateswaran, S., Manganelli, R., & Barzon, L. (2020) · Cells · doi:10.3390/cells9102160 · Cited by 116
B-Cells and Antibodies as Contributors to Effector Immune Responses in Tuberculosis
Rijnink, W. F., Ottenhoff, T. H. M., & Joosten, S. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.640168 · Cited by 129
Self-citationAcquired immunodeficiencies and tuberculosis: focus on HIV / AIDS and diabetes mellitus
Ronacher, K., Joosten, S. A., van Crevel, R., Dockrell, H. M., Walzl, G., & Ottenhoff, T. H. M. (2015) · Immunological Reviews · doi:10.1111/imr.12257 · Cited by 112
“In subsequent studies, biomarker signatures were identified that performed almost equally well in TB patients with or without HIV co-infection, both in infants and in adults (146, 147).”
BackgroundSelf-citationRhinovirus Detection in Symptomatic and Asymptomatic Children: Value of Host Transcriptome Analysis
Heinonen, S., Jartti, T. T., García, C., Oliva, S., Smitherman, C., Anguiano, E., Piters, W. A. A. D. S., Vuorinen, T., Ruuskanen, O., Dimo, B., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0749oc · Cited by 113
Diagnostic biomarkers for active tuberculosis: progress and challenges
Nogueira, B. M. F., Krishnan, S., Barreto‐Duarte, B., Araújo‐Pereira, M., Queiroz, A. T. L., Ellner, J. J., Salgame, P., Scriba, T. J., Sterling, T. R., Gupta, A., et al. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202114088 · Cited by 123
Blankley, S., Graham, C. M., Turner, J., Berry, M. P. R., Bloom, C. I., Xu, Z., Pascual, V., Banchereau, J., Chaussabel, D., Breen, R. A. M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162220 · Cited by 105
Chakraborty, S. K. (2024) · Sensors & Diagnostics · doi:10.1039/d3sd00304c · Cited by 144
Yong, Y. K., Tan, H. Y., Saeidi, A., Wong, W. F., Vignesh, R., Velu, V., Eri, R. D., Larsson, M., & Shankar, E. M. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02789 · Cited by 112
Tryptophan catabolism reflects disease activity in human tuberculosis
Collins, J. M., Siddiqa, A., Jones, D. P., Liu, K., Kempker, R. R., Nizam, A., Shah, N. S., Ismail, N. A., Ouma, S. G., Tukvadze, N., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.137131 · Cited by 103
“children, levels of IDO-1 expression were similar in LTBI and active TB, and both children with LTBI and those with active TB demonstrated significantly higher IDO-1 expression versus controls with diseases other than TB and no evidence of LTBI (42).”
ResultPintye, J. C., Drake, A. L., Kinuthia, J., Unger, J. B., Matemo, D. N., Heffron, R. A., Barnabas, R. V., Kohler, P. K., McClelland, R. S., & John-Stewart, G. C. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw850 · Cited by 105
Kawasaki Disease: Global Burden and Genetic Background
Elakabawi, K., Lin, J., Jiao, F., Guo, N., & Yuan, Z. (2020) · Cardiology Research · doi:10.14740/cr993 · Cited by 95
Genome‐wide host RNA signatures of infectious diseases: discovery and clinical translation
Gliddon, H. D., Herberg, J. A., Levin, M., & Kaforou, M. (2017) · Immunology · doi:10.1111/imm.12841 · Cited by 102
“In cases where a gene expression signature should be applicable regardless of background endemic infections or HIV infection, both rural and urban populations should be recruited, as well as HIVinfected and –uninfected participants [23] [24].”
BackgroundSelf-citationCirculating microRNAs as biomarkers for the early diagnosis of childhood tuberculosis infection
ZHOU, M., YU, G., YANG, X., ZHU, C., ZHANG, Z., & ZHAN, X. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5097 · Cited by 92
Rohlwink, U. K., Figaji, A., Wilkinson, K. A., Horswell, S. D., Sesay, A. K., Deffur, A., Enslin, N., Solomons, R., van Toorn, R., Eley, B., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11783-9 · Cited by 95
Self-citationBlood Transcriptomic Stratification of Short-term Risk in Contacts of Tuberculosis
Roe, J. K., Venturini, C., Gupta, R. K., Gurry, C., Chain, B., Sun, Y., Southern, J., Jackson, C., Lipman, M. C. I., Miller, R. F., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz252 · Cited by 83
Méndez‐Samperio, P. (2017) · Scandinavian Journal of Immunology · doi:10.1111/sji.12567 · Cited by 83
Diagnostic ‘omics’ for active tuberculosis
Haas, C. T., Roe, J. K., Pollara, G., Mehta, M., & Noursadeghi, M. (2016) · BMC Medicine · doi:10.1186/s12916-016-0583-9 · Cited by 84
“Patients with LTBI were defined by the absence of signs or symptoms of active TB, and a positive IGRA and TST. Healthy controls had no symptoms or signs of TB and a negative IGRA and TST. Differentially expressed genes between active TB and healthy states (both LTBI and healthy controls) were identified in the trainin…”
BackgroundMethodResultInfluentialHoneyborne, I., McHugh, T. D., Kuittinen, I., Cichońska, A., Evangelopoulos, D., Ronacher, K., van Helden, P. D., Gillespie, S. H., Fernández-Reyes, D., Walzl, G., et al. (2016) · BMC Medicine · doi:10.1186/s12916-016-0609-3 · Cited by 79
“However, molecular profiling assays, such as those used to identify tuberculosis disease from patient blood transcriptional signatures [13, 14], have not been applied to bacteria during patient drug therapy to assess the predictive power of dynamic bacterial responses to antimicrobial drug exposure.”
BackgroundCytomegalovirus infection is a risk factor for tuberculosis disease in infants
Müller, J., Tanner, R., Matsumiya, M., Snowden, M. A., Landry, B., Satti, I., Harris, S. A., Tanner, R., O’Shea, M. K., Stockdale, L. K., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.130090 · Cited by 78
Managing latent tuberculosis infection and tuberculosis in children
Carvalho, I., Goletti, D., Manga, S., Silva, D. R., Manissero, D., & Migliori, G. B. (2018) · Pulmonology · doi:10.1016/j.rppnen.2017.10.007 · Cited by 88
Jaggi, P., Mejías, A., Xu, Z., Yin, H., Moore‐Clingenpeel, M., Smith, B., Burns, J. C., Tremoulet, A. H., Jordán-Villegas, A., Chaussabel, D., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197858 · Cited by 68
Counting children with tuberculosis: why numbers matter
Seddon, J. A., Jenkins, H. E., Liu, L., Cohen, T., Black, R. E., Vos, T., Becerra, M. C., Graham, S. M., Sismanidis, C., & Dodd, P. J. (2015) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.15.0471 · Cited by 78
Bhattacharya, S., Rosenberg, A. F., Peterson, D. R., Grzesik, K., Baran, A. M., Ashton, J. M., Gill, S. R., Corbett, A. M., Holden‐Wiltse, J., Topham, D. J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06738-3 · Cited by 68
Mass Spectrometric Identification of Urinary Biomarkers of Pulmonary Tuberculosis
Isa, F., Collins, S. E., Lee, M. H., Decome, D., Dorvil, N., Joseph, P., Smith, L., Salerno, S. M., Wells, M. T., Fischer, S. M., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.04.014 · Cited by 73
Complement Component C1q as Serum Biomarker to Detect Active Tuberculosis
Lubbers, R., Sutherland, J. S., Goletti, D., de Paus, R. A., van Moorsel, C. H. M., Veltkamp, M., Vestjens, S. M. T., Bos, W. J. W., Petrone, L., Nonno, F. D., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02427 · Cited by 63
Self-citationA rapid triage test for active pulmonary tuberculosis in adult patients with persistent cough
Ahmad, R., Xie, L., Pyle, M., Fernández-Suárez, M., Broger, T., Steinberg, D., Ame, S. M., Lucero, M., Szucs, M. J., MacMullan, M. A., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw8287 · Cited by 73
“HIV positive (%) 35 (17) 25 (33) 17 (61) 77 (24)”
Wang, B., Chen, S., Zheng, Q., Li, Y., Zhang, X., Xuan, J., Liu, Y., & Shi, G. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102590 · Cited by 74
The current epidemiology and clinical decisions surrounding acute respiratory infections
Zaas, A. K., Garner, B. H., Tsalik, E. L., Burke, T. W., Woods, C. W., & Ginsburg, G. S. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.08.001 · Cited by 68
Biomarkers for diagnosis of childhood tuberculosis: A systematic review
Togun, T. O., MacLean, E. L.-H., Kampmann, B., & Pai, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204029 · Cited by 69
“Two studies were deemed to have used purposive sampling by conducting biomarker analysis on a sub-selection of eligible subjects because of cost [37], or by excluding IGRA positive children with other respiratory diseases in their discovery cohort [36].”
BackgroundHost Protein Biomarkers Identify Active Tuberculosis in HIV Uninfected and Co-infected Individuals
Achkar, J. M., Cortes, L., Croteau, P., Yanofsky, C. M., Mentinova, M., Rajotte, I., Schirm, M., Zhou, Y., Junqueira‐Kipnis, A. P., Kasprowicz, V. O., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.07.039 · Cited by 73
“…were also able to identify signatures specific to TB through analysis of changes related to immune cell activation, although comparatively large panels of 44–86 biomarker genes were necessary to distinguish TB from other diseases (Anderson et al., 2014; Kaforou et al., 2013; Berry et al., 2010).”
BackgroundResultInfluentialImpact of the GeneXpert MTB/RIF Technology on Tuberculosis Control
Stevens, W. S., Scott, L. E., Noble, L. D., Gous, N. M., & Dheda, K. U. J. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0040-2016 · Cited by 71
Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model
Heyckendorf, J., Marwitz, S., Reimann, M., Avsar, K., DiNardo, A. R., Günther, G., Höelscher, M., Ibraim, E., Kalsdorf, B., Kaufmann, S. H. E., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.03492-2020 · Cited by 59
New Diagnostics for Childhood Tuberculosis
Chiang, S. S., Swanson, D. S., & Starke, J. R. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.05.011 · Cited by 62
Geake, J. B., Hammerschlag, G., Nguyen, P., Wallbridge, P. D., Jenkin, G., Korman, T. M., Jennings, B. R., Johnson, D. F., Irving, L. B., Farmer, M. W., et al. (2015) · PubMed Central · doi:10.3978/j.issn.2072-1439.2015.01.33 · Cited by 64
“, highly probable TB, as previously defined (22,23).”
BackgroundNew tuberculosis diagnostics and rollout
McNerney, R., Cunningham, J. A., Hepple, P., & Zumla, A. I. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.01.012 · Cited by 64
“Similarly, attempts to map host RNA transcriptional signatures to detect and differentiate active disease have revealed a complex picture.(49,50)”
BackgroundDiagnostic Tests for Childhood Tuberculosis
Tebruegge, M., Ritz, N., Curtis, N. C., & Shingadia, D. V. (2015) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000796 · Cited by 60
Lee, H. J., Georgiadou, A., Otto, T. D., Levin, M., Coin, L., Conway, D. J., & Cunnington, A. J. (2018) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00071-17 · Cited by 65
“…that have similar clinical presentations, such as distinguishing bacterial from viral infection (208) or tuberculosis from nontuberculous infection (209), demonstrating a proof of principle that each disease has a unique transcriptional signature that might form the basis of a rapid test to guide…”
BackgroundSelf-citationClifford, V., Tebruegge, M., Zufferey, C., Germano, S., Forbes, B., Cosentino, L., Matchett, E., McBryde, E. S., Eisen, D. P., Robins-Browne, R. M., et al. (2018) · Tuberculosis · doi:10.1016/j.tube.2018.08.011 · Cited by 59
Darboe, F., Mbandi, S. K., Naidoo, K., Yende‐Zuma, N., Lewis, L., Thompson, E. G., Duffy, F. J., Fisher, M., Filander, E., van Rooyen, M., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01441 · Cited by 59
Walter, N. D., Miller, M. A., Vasquez, J., WEINER, M. H., Chapman, A., Engle, M., Higgins, M. P., Quinones, A., Rosselli, V., Canono, E., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01990-15 · Cited by 68
“In early phase studies (12), blood transcriptional classifiers have shown promise for active TB diagnosis (3, 10, 11, 13, 14) and for monitoring treatment response (15).”
BackgroundMethodAhmed, M. I. M., Ntinginya, N. E., Kibiki, G. S., Mtafya, B., Semvua, H. H., Mpagama, S. G., Mtabho, C., Saathoff, E., Held, K., Loose, R., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02247 · Cited by 64
Hoang, L. T., Jain, P., Pillay, T. D., Tolosa-Wright, M., Niazi, U. H. K., Takwoingi, Y., Halliday, A., Berrocal-Almanza, L. C., Deeks, J. J., Beverley, P. C. L., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30928-2 · Cited by 68
Host Gene Expression in Nose and Blood for the Diagnosis of Viral Respiratory Infection
Yu, J., Peterson, D. R., Baran, A. M., Bhattacharya, S., Wylie, T., Falsey, A. R., Mariani, T. J., & Storch, G. A. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy608 · Cited by 61
Gliddon, H. D., Kaforou, M., Alikian, M., Habgood-Coote, D., Zhou, C., Oni, T., Anderson, S. T. B., Brent, A., Crampin, A. C., Eley, B., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637164 · Cited by 62
“All four of these genes were identified in the 44 gene expression signature for TB/OD, and although GBP6 is induced by the interferon (IFN) cytokine family, its levels were significantly higher in active TB cases when compared to confirmed viral and bacterial infections the GSE73464 (32) and GSE39941 (33) datasets (Su…”
ResultSelf-citationA tuberculosis biomarker database: the key to novel TB diagnostics
Yerlikaya, S., Broger, T., MacLean, E. L.-H., Pai, M., & Denkinger, C. M. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.01.025 · Cited by 59
Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis and Disease Outcome
Duffy, F. J., Weiner, J. M., Hansen, S. G., Tabb, D. L., Suliman, S., Thompson, E. G., Maertzdorf, J., Shankar, S., Tromp, G., Parida, S. K., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00527 · Cited by 57
Self-citationOlbrich, L., Verghese, V. P., Franckling-Smith, Z., Sabi, I., Ntinginya, N. E., Mfinanga, A., Banze, D., Viegas, S. O., Khosa, C., Semphere, R., et al. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00491-7 · Cited by 53
LaCourse, S. M., Cranmer, L. M., Matemo, D. N., Kinuthia, J., Richardson, B. A., John-Stewart, G. C., & Horne, D. J. D. L. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000826 · Cited by 53
Novel transcriptional signatures for sputum-independent diagnostics of tuberculosis in children
Gjøen, J. E., Jenum, S., Sivakumaran, D., Mukherjee, A., Macaden, R., Kabra, S. K., Lodha, R., Ottenhoff, T. H. M., Haks, M. C., Doherty, T. M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05057-x · Cited by 50
Self-citationPediatric Tuberculosis Management: A Global Challenge or Breakthrough?
Maphalle, L. N. F., Michniak‐Kohn, B. B., Ogunrombi, M. O., & Adeleke, O. A. (2022) · Children · doi:10.3390/children9081120 · Cited by 92
“It is important that preventative options that are to be developed should cater to all pediatric groups, including HIV-positive children.”
BackgroundInfluentialde Araujo, L. S., Vaas, L. A. I., Ribeiro-Alves, M., Geffers, R., Mello, F. C. Q., de Almeida, A. S., Moreira, A. D. S. R., Kritski, A. L., Lapa e Silva, J. R., Moraes, M. O., et al. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01586 · Cited by 49
“…Evandro Chagas, Rio de Janeiro, Brazil, 4 Helmholtz Centre for Infection Research, Braunschweig, Germany, 5 Thoracic Diseases Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil, 6 Laboratório de Hanseníase, Fundação Oswaldo Cruz, Instituto Oswaldo Cruz, Rio de Janeiro,…”
BackgroundInfluentialEsposito, S., Rinaldi, V. E., Argentiero, A., Farinelli, E., Cofini, M., D’Alonzo, R., Mencacci, A., & Principi, N. (2018) · Mediators of Inflammation · doi:10.1155/2018/4869329 · Cited by 53
Advances in the understanding of Mycobacterium tuberculosis transmission in HIV-endemic settings
Peters, J. S., Andrews, J. R., Hatherill, M., Hermans, S., Martínez, L., Schurr, E., van der Heijden, Y. F., Wood, R., Rustomjee, R., & Kana, B. D. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30477-8 · Cited by 48
Genetic Resistance to Mycobacterium tuberculosis Infection and Disease
Möller, M., Kinnear, C. J., Orlova, M., Kroon, E. E., van Helden, P. D., Schurr, E., & Hoal, E. G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02219 · Cited by 62
Genetics and evolution of tuberculosis pathogenesis: New perspectives and approaches
McHenry, M. L., Williams, S. M., & Stein, C. M. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104204 · Cited by 51
Gene expression signatures identify biologically and clinically distinct tuberculosis endotypes
DiNardo, A. R., Gandhi, T., Heyckendorf, J., Grimm, S. L., Rajapakshe, K., Nishiguchi, T., Reimann, M., Kirchner, H. L., Kahari, J., Dlamini, Q., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.02263-2021 · Cited by 48
“Studies included both microarray[2-8] and genome-wide (RNA-seq)[9, 10] gene expression analyses (Supplemental Table 1).”
MethodDeshpande, G., Beetch, J. E., Heller, J. G., Naqvi, O. H., & Kuhn, K. G. (2023) · Microorganisms · doi:10.3390/microorganisms12010050 · Cited by 64
“Categorization through gene expression profiling has proven beneficial in recognizing different infections, such as Staphylococcal bacteremia [84], distinguishing between active and latent tuberculosis [85] and identifying influenza [86] and COVID-19 [87].”
Rosenbaum, J. T., Choi, D., Wilson, D. J., Grossniklaus, H. E., Harrington, C. A., Sibley, C. H., Dailey, R. A., Ng, J. D., Steele, E. A., Czyz, C. N., et al. (2015) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2015.0726 · Cited by 49
Transcriptomic Analysis of CD4+ T Cells Reveals Novel Immune Signatures of Latent Tuberculosis
Burel, J. G., Arlehamn, C. S. L., Khan, N., Seumois, G., Greenbaum, J., Taplitz, R., Gilman, R. H., Saito, M., Vijayanand, P., Sette, A., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800118 · Cited by 53
Chukwudozie, O. S., Duru, V. C., Ndiribe, C. C., Aborode, A. T., Oyebanji, V. O., & Emikpe, B. O. (2021) · Bioinformatics and Biology Insights · doi:10.1177/11779322211002168 · Cited by 54
Bobak, C. A., Abhimanyu, A., Natarajan, H., Gandhi, T., Grimm, S. L., Nishiguchi, T., Koster, K. J., Longlax, S. C., Dlamini, Q., Kahari, J., et al. (2022) · Aging · doi:10.18632/aging.203936 · Cited by 53
“Finally, the last cohort included children, with and without HIV co-infection [18].”
BackgroundThe Role of Host Genetics (and Genomics) in Tuberculosis
Naranbhai, V. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0011-2016 · Cited by 45
Metadata
- Authors
- Anderson, S. T., Kaforou, M., Brent, A. J., Wright, V. J., Banwell, C. M., Chagaluka, G., Crampin, A. C., Dockrell, H. M., French, N., Hamilton, M. S., Hibberd, M. L., Kern, F., Langford, P. R., Ling, L., Mlotha, R., Ottenhoff, T. H. M., Pienaar, S., Pillay, V., Scott, J. A. G., Twahir, H., Wilkinson, R. J., Coin, L. J., Heyderman, R. S., Levin, M., & Eley, B.
- Affiliations
- Brighton and Sussex Medical School (GB)
- Imperial College London (GB)
- Kenya Medical Research Institute (KE)
- Wellcome Trust (GB)
- University of Malawi (MW)
- University of Liverpool (GB)
- Genome Institute of Singapore (SG)
- Leiden University Medical Center (NL)
- Red Cross War Memorial Children's Hospital (ZA)
- Institute of Infectious Disease and Molecular Medicine (ZA)
- The University of Queensland (AU)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-05
- Volume
- 370
- Issue
- 18
- Pages
- 1712-1723
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4069985
- OpenAlex
- W2145559868
- Cited by
- 379
- References
- 36
- Citations by year
- 2026: 12 · 2025: 18 · 2024: 33 · 2023: 28 · 2022: 27 · 2021: 35 · 2020: 35 · 2019: 31 · 2018: 40 · 2017: 29 · 2016: 37 · 2015: 46 · 2014: 8
- FWCI
- 28.12
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- LSTM Online Archive (Liverpool School of Tropical Medicine) (acceptedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Sussex Research Online (University of Sussex) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
- Funders
- Wellcome Trust (101113, 088316, 077092, 104803/Z/14/Z, 084679, 081697, 100714, 092654, 100890, 098532/B/12/Z, 098532, 84323, 081835, 084323)
- National Institute for Health and Care Research (NF-SI-0611-10230)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Keywords
- pediatric tuberculosis, tuberculosis diagnosis, blood transcriptome, latent tuberculosis infection, HIV coinfection, culture-negative tuberculosis, Xpert MTB/RIF, sensitivity and specificity, African children
- MeSH terms
- Africa, Algorithms, Bacteriological Techniques, Child, Child, Preschool, Diagnosis, Differential, Humans, Infant, Male, Mycobacterium tuberculosis, Risk, RNA, Bacterial, Sensitivity and Specificity, Tuberculosis, HIV Infections, Oligonucleotide Array Sequence Analysis, Latent Tuberculosis, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.